Investor Relations

Redpoint Bio is leveraging recent discoveries in the molecular biology of taste to discover and develop novel taste modulators for the food and beverage industries. Redpoint is focused on the development of healthier foods and beverages as well as new approaches to the treatment of diabetes and obesity.

Recent scientific research suggests that many of the same taste-signaling components found on the tongue are also expressed as part of a nutrient-sensing system located in the gastrointestinal tract. This could lead to potential opportunities for the discovery of novel diabetes or obesity therapeutics.

Stock Information

RPBC - (OTC: BB) 0.22 + 0.03 Jul 2, 2009 3:47 PM

Recent Releases

Jun 23, 2009
Redpoint Bio Identifies All-Natural Sweetness Enhancer For Use in Food and Beverages

May 18, 2009
Redpoint Bio Announces Workforce Reduction

Events

Jun 23, 2009
Investor Presentation

Mar 7, 2008
EQUITIES Magazine Article, March 2008